Venus Remedies Key Metrics

BSE: 526953 | NSE: VENUSREM | ISIN: INE411B01019 | Sector: Biotechnology & Drugs

299.90 +7.85 (2.69%)Updated : 25 Nov 2024

Ratios

Return on average equity - 5 year average	7.25
Net Income/employee - trailing 12 month	1,86,274.60
Revenue/employee - most recent fiscal year	55,05,260.00
Return on investment - most recent fiscal year	5.35
Return on average assets - most recent fiscal year	4.64
Receivables turnover - most recent fiscal year	7.65
Return on investment - trailing 12 month	4.06
Return on average assets - trailing 12 month	3.40
Inventory turnover - most recent fiscal year	3.01
Inventory turnover - trailing 12 month	2.68
Revenue/employee - trailing 12 month	51,78,093.00
Return on average assets - 5 year average	4.82
Net Income/employee - most recent fiscal year	2,60,785.40
Return on average equity - trailing 12 month	4.58
Receivables turnover - trailing 12 month	8.72
Asset turnover - most recent fiscal year	0.98
Asset turnover - trailing 12 month	0.94
Return on average equity - most recent fiscal year	6.01
Return on investment - 5 year average	6.17